Skip to content

Clinical trials

Phase 3 Ischemic Stroke trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 3 Country / region: Canada Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20092
20101
20131
20142
20171
20182
20201
20231
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7
Completed6
Recruiting3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Calgary3
Acorda Therapeutics1
Bayer1
CSL Behring1
Columbia University1
D-Pharm Ltd.1
Forest Laboratories1
H. Lundbeck A/S1
Janssen Research & Development, LLC1
Joseph Broderick1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke18
Stroke12
Atrial Fibrillation2
Thrombosis2
Acute Coronary Syndrome1
Atherosclerosis1
Cardiovascular Diseases1
Cerebral Hemorrhage1
Cerebrovascular Disorders1
Coronary Artery Disease1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.